FDA Commissioner Confirmation Clears The Way For Personnel Changes
This article was originally published in The Tan Sheet
The confirmation of FDA Commissioner Lester Crawford will allow for a reorganization of upper level management at the agency
You may also be interested in...
The confirmation of Lester Crawford as FDA Commissioner gives him three and a half years to cement his leadership, which has been under fire during his service as acting commissioner
Deputy Commissioner for Policy Amit Sachdev formally resigns from the agency, Acting Commissioner Lester Crawford announces in an internal memorandum. Crawford cited Sachdev's work with Congress on FDA oversight, his contributions to expanding the agency's access to more resources for its various centers and leadership in speeding up review of medicines to treat HIV/AIDS under the White House's global AIDS initiative. Sachdev, whose last day was March 25, has not disclosed his future plans...
FDA Commissioner Mark McClellan, MD/PhD, is leaving FDA before the agency makes a decision on whether Barr Labs' Plan B (levenorgestrel .75 mg) is approvable for over-the-counter use